Great Falls Clinic Open Research Studies
Learn more about Great Falls Clinic’s Clinical Research Department.
ATB200-02: Phase I/II
CAIN457H2315: Phase III
Treating: Axial Spondyloarthritis
Indication: Active non-radiographic Axial Spondyloarthritis
Status: Open and Currently Not Enrolling
A randomized, double-blind, placebo-controlled multicenter study of secukinumab to evaluate the safety, tolerability and efficacy up to 2 years in patients with active nonradiographic axial spondyloarthritis
CAIN457K2340: Phase III
CIRT: Cardiovascular Inflammation Reduction Trial
Treating: Cardiac
Status: Open and Not Currently Enrolling
A randomized, double-blind placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome.
D1699C00001: Phase III
DECLARE: Phase IIIb
Treating: Cardiac
Status: Not Currently Enrolling
A multicenter, randomized, double blind, placebo-controlled trial to evaluate the effect of Dapagliflozin 10mg once daily on the incidence of cardiovascular death, myocardial infarction or ischemic stroke in patients with type 2 diabetes.
Meet Our Providers
Pediatrics
Pediatrics
Heart Center
Family Practice